BAYLOR COLLEGE OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Treatment of Subarachnoid Hemorrhage With Human Albumin
Not Applicable
Terminated
- Conditions
- Subarachnoid Hemorrhage
- Interventions
- Drug: 25% human albumin
- First Posted Date
- 2006-01-27
- Last Posted Date
- 2015-04-01
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 47
- Registration Number
- NCT00283400
- Locations
- 🇺🇸
The Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸Baylor College of Medicine, Houston, Texas, United States
🇨🇦University of Toronto, Toronto, Ontario, Canada
Steroid Treatment for Sickle Cell Pain Crisis
Phase 3
Terminated
- Conditions
- Sickle Cell DiseaseVaso-occlusive Crisis
- Interventions
- Drug: Steroid armOther: Placebo
- First Posted Date
- 2005-12-09
- Last Posted Date
- 2020-07-07
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 18
- Registration Number
- NCT00263562
- Locations
- 🇺🇸
Texas Childrens Hospital, Houston, Texas, United States
Sleep, HIV Disease Progression, and Function in HIV Infected Children and Adolescents
Completed
- Conditions
- SleepHIV Infections
- First Posted Date
- 2005-11-15
- Last Posted Date
- 2013-03-28
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 90
- Registration Number
- NCT00253695
- Locations
- 🇺🇸
Texas Children's Hospital/Baylor College of Medicine, Houston, Texas, United States
Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
Not Applicable
Completed
- Conditions
- Cardiovascular DiseasesHeart DiseasesHIV InfectionsHyperlipidemiaHypertriglyceridemiaInsulin ResistanceAtherosclerosis
- Interventions
- First Posted Date
- 2005-10-30
- Last Posted Date
- 2016-03-21
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 221
- Registration Number
- NCT00246376
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Lymphocytic B-Leukemia (B-CLL) w/Human IL-2 Gene Modified & Human CD40 Ligand-Expressing Autologous Tumor Cells
Phase 1
Withdrawn
- Conditions
- CHRONIC LYMPHOCYTIC B-LEUKEMIA
- First Posted Date
- 2005-09-23
- Last Posted Date
- 2012-05-21
- Lead Sponsor
- Baylor College of Medicine
- Registration Number
- NCT00224354
Lantus in the Treatment of Type 1 Diabetes Children
Phase 4
Completed
- Conditions
- Type 1 Diabetes
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 60
- Registration Number
- NCT00206401
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Ability to Cope With Type 1 Diabetes
Completed
- Conditions
- Depression
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 220
- Registration Number
- NCT00206349
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
The Role of Amylin and Glucagon in T1DM
Phase 3
Completed
- Conditions
- Type 1 Diabetes
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT00206258
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes
Phase 3
Completed
- Conditions
- Type 1 Diabetes
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT00206297
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT00206336
© Copyright 2025. All Rights Reserved by MedPath